Scottsdale, AZ - (WORLD
STOCK WIRE) - March 3, 2008 -- eFoodSafety.com, Inc. (OTCBB: EFSF,
www.efoodsafety.com), through its wholly-owned subsidiary Knock-Out
Technologies Ltd., has developed and will begin clinical testing of
Proxorin(TM), based on the company's Citroxin(TM) formula, for use as a
natural antibiotic/anti-microbial for treatment against a broad
spectrum of common bacterial pathogens. Unlike many antibiotics, which
often have a limited range of applications, Proxorin's natural
composition allows it to be used in a range of conditions where
anti-microbials are needed.
As an antibiotic, Proxorin can offer
several advantages over common drug-based antibiotics. Its ability to
confer its benefits against both gram-negative and gram-positive
bacteria enables it to be used to treat a broad spectrum of bacterial
pathogens. Proxorin also produces far fewer side effects than other
common antibiotic pharmaceuticals, thereby reducing the likelihood of
rebound infections. In addition, Proxorin can provide benefits to those
patients who experience allergic reactions to a spectrum of "cillin"
drugs. Finally, an enormous problem for the normal armament of
antibiotics is the potential for "bugs" to develop resistance to the
beneficent effects of a given antibiotic--a scenario that is highly
unlikely to occur with Proxorin.
Initial microbial inhibition
tests prove Proxorin extremely effective in eradicating MRSA, the
methicillin resistant form of Staphylococcus aurous, and other studies
of the formula show a 100% kill rate for common bacteria including: E.
coli, Listeria, Pseudomonas, Salmonella, Staphylococcus, and
Streptococcus. eFoodSafety expects to offer the antibiotic both as a
high potency pill for oral ingestion and as a trans-dermal cream. These
two forms utilize proprietary technology to offer controlled and
targeted release of the active compounds to ensure maximum
bio-availability and benefits.
"The decision to conduct clinical
testing of Proxorin as a natural antibiotic is based on the encouraging
microbial inhibition test results showing its ability to eradicate MRSA
as other common bacterial pathogens," says Robert Bowker, President of
Knock-Out Technologies. "These widespread bacterial pathogens are
becoming increasingly difficult and expensive to defeat using
conventional pharmaceutical methods. Importantly, eFoodSafety can offer
Proxorin as both a high potency pill for oral ingestion and as a
trans-dermal cream that provides effective absorption without having to
go through normal digestion. We believe that with positive clinical
results, our natural treatment can provide a superior solution to
patients seeking treatment."
About eFoodSafety.com, Inc.
eFoodSafety.com,
Inc. is dedicated to improving health conditions around the world
through its innovative technologies. The company's Knock-Out
Technologies, Ltd. subsidiary has developed an environmentally safe
sporicidal product formulated entirely of food-grade components that
eradicates anthrax and a germicidal product, Citroxin(TM) (formerly
named Big Six Plus) - EPA Reg. No. 82723-1 that kills six major
bacteria: E-coli, Listeria, Pseudomonas, Salmonella, Staphylococcus,
and Streptococcus, Avian Influenza, and Black Mold. The sporicidal
product has completed its final efficacy laboratory study requisite for
EPA registration. In the study, it eradicated both Clostridium
Sporogenes and Bacillus Subtilis with 100% efficacy on both hard and
porous surfaces. The OraPhyte(TM) product, which has been tested and
shown to be effective at eradicating nematodes by the U.S. Department
of Agriculture, is currently at three major universities with
outstanding Agricultural Departments undergoing crop-specific research.
The
Company is the owner of Cinnergen(TM), a clinically-studied,
non-prescription liquid whole food nutritional supplement that promotes
healthy glucose metabolism available for sale at (www.cinnergen.com)
and through national retailers; and Cinnechol(TM), a multi-faceted
nutritional supplement specifically designed to naturally reduce total
cholesterol levels without causing any side effects. The Company has
entered into a joint venture agreement with CK41 Direct, Inc. to launch
the PurEffect(TM) anti-acne skin care system.
The company's
iBoost, Inc. subsidiary is the distributor of the Immune Boost Bar(TM),
a non-dairy, no refined sugar, all-natural and comprehensive
multi-nutrient product that helps fortify the body's immune system. The
product contains Citroxin(TM), eFoodSafety's proprietary all natural
supplement proven effective in fighting several types of harmful
bacteria, and forty active compounds that assist with enhancing
immunity, detoxification, cleansing, and metabolic efficiency. The
Immune Boost Bar(TM) is available in three delicious flavors:
chocolate, oatmeal-raisin, and orange-apple and can be purchased at
www.immuneboost.com.
The company's MedElite, Inc. subsidiary
distributes clinically proven products to physicians who then prescribe
the products for their patients. It recently became the owner of the
Talsyn(TM)-CI/bid Scar Cream, that has been clinically proven to
facilitate and improve the appearance, redness and strength of scars
(www.talsyn.com), as well as seven (7) other products in the Talsyn(TM)
line.
Please visit the Company's website at: http://www.efoodsafety.com.
Safe Harbor Forward-Looking Statements
Statements
contained in this release that are not strictly historical are
"forward-looking statements." Such forward-looking statements are
sometimes identified by words such as "intends," "anticipates,"
"believes," "expects" and "hopes." The forward-looking statements are
made based on information available as of the date hereof, and the
Company assumes no obligation to update such forward-looking
statements. Editors and investors are cautioned that such
forward-looking statements involve risks and uncertainties that could
cause the Company's actual results to differ materially from those in
these forward-looking statements. Such risks and uncertainties include
but are not limited to demand for the Company's products and services,
our ability to continue to develop markets, general economic
conditions, our ability to secure additional financing for the Company
and other factors that may be more fully described in reports to
shareholders and periodic filings with the Securities and Exchange
Commission.
Patricia Gruden
efoodsafety.com, Inc.
7702 East Doubletree Ranch Road
Suite 300
Scottsdale, AZ 85258
USA
Phone: 415-884-0348
Fax: 480-348-3999
Source: efoodsafety.com, Inc.
Note:
The following press release was submitted by: efoodsafety.com, Inc.,
and World Stock Wire, Inc. is not liable for the contents of this press
release.
| ||||||||||||||||